Skip to main content
Account

Peer review reports

From: Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results

Original Submission
4 Jun 2020 Submitted Original manuscript
15 Jun 2020 Reviewed Reviewer Report
8 Jul 2020 Reviewed Reviewer Report
17 Aug 2020 Author responded Author comments - Makoto Ueno
Resubmission - Version 2
17 Aug 2020 Submitted Manuscript version 2
18 Aug 2020 Reviewed Reviewer Report
19 Aug 2020 Reviewed Reviewer Report
27 Aug 2020 Author responded Author comments - Makoto Ueno
Resubmission - Version 3
27 Aug 2020 Submitted Manuscript version 3
Publishing
31 Aug 2020 Editorially accepted
16 Nov 2020 Article published 10.1186/s12885-020-07365-4

Learn about peer review

Back to article page

Navigation